Application of metabolomics in drug-resistant epilepsy research
Poster Dec 07, 2015
Federica Murgia1, Simone Poddighe1, Francesco Del Carratore1, Lorenzo Polizzi2, Antonella Muroni2, Luigi Barberini3, Monica Puligheddu3, Francesco Marrosu2 , Luigi Atzori1
Introduction: Drug resistance is a critical issue in the treatment of epileptic patients. One third of people with epilepsy are resistant to old and new antiepileptic drugs. Metabolomics could provide a tool to investigate possible markers of drug resistance in a population of epileptic subjects suggesting also a possible mechanism. Materials and methods: Blood samples were collected from 3 groups: 1) healthy patients (n=35); 2) patients “responder” (R) to the drug therapy (n=18), and 3) patients “not responder” (NR) (n=17). The samples were analysed by using a Varian UNITY INOVA 500 spectrometer. Multivariate statistical analysis was performed by using SIMCA-P+ software. The metabolites corresponding to the discriminant variables were identified and quantified by using Chenomx software. Results: A different metabolic profile was identified for the three different groups. In particular, the group of the pathological patients were characterized by an increase of acetate, acetoacetate, acetone and scyllo-inositol compared to controls group, and a decrease in lactate, glucose and citrate. The metabolic fingerprint of the class of NR was significantly different from R based on increased levels of ketone bodies. Conclusions: Metabolomics represents an important tool for biomarker discovery in drug-resistant epilepsy and for the study of the pathophysiology of this disease.
LC-SWATH/MS Metabolomics Platform with Hyphenation of Extraction for the Analysis of Polar and Non-polar Metabolites in Biological SamplesPoster
Automated robotic sample preparation with hyphenated dual LC-SWATH/MS analysis for lipids and polar metabolites.
Investigating the Effects of Fructose Consumption and Inadequate Copper Intake on Nonalcoholic Fatty Liver DiseasePoster
Metabolomics is a viable method for identifying compounds associated with NAFLD. In this investigation, high-quality data facilitate the identification of key metabolites differentiating normal versus diseased species.READ MORE
A Tissue-based Proteomic Study of VEGFR2 in Human Term PlacentasPoster
VEGFR2 is the main regulator of placental angiogenesis and at term is localized in endothelial cells (EC) of the villous vasculature. VEGFR2 immunoprecipitation (IP) of membrane proteins, extracted from the fetal compartment, isolated 30 proteins that were identified by proteomic analysis.READ MORE